Results 21 to 30 of about 389,571 (303)

Differences in inflammatory marker profiles and cognitive functioning between deficit and nondeficit schizophrenia

open access: yesFrontiers in Immunology, 2022
Deficit schizophrenia (DS) patient is a homogenous subtype of schizophrenia that includes primary and enduring negative symptoms. This study aimed to compare the differences in cognitive functioning and plasma levels of C-reactive protein (CRP) and ...
Dandan Wang   +8 more
doaj   +1 more source

A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia [PDF]

open access: yes, 2009
We report a genome-wide assessment of single nucleotide polymorphisms (SNPs) and copy number variants (CNVs) in schizophrenia. We investigated SNPs using 871 patients and 863 controls, following up the top hits in four independent cohorts comprising 1 ...
Rujescu, D.   +218 more
core   +1 more source

Schizophrenia

open access: yesThe Lancet, 2022
Schizophrenia, characterised by psychotic symptoms and in many cases social and occupational decline, remains an aetiological and therapeutic challenge. Contrary to popular belief, the disorder is modestly more common in men than in women. Nor is the outcome uniformly poor.
Jauhar, Sameer   +2 more
openaire   +3 more sources

Local and global limits on visual processing in schizophrenia. [PDF]

open access: yes, 2015
Schizophrenia has been linked to impaired performance on a range of visual processing tasks (e.g. detection of coherent motion and contour detection).
Steven C. Dakin   +33 more
core   +1 more source

Rethinking Schizophrenia in the Context of Normal Neurodevelopment

open access: yesFrontiers in Cellular Neuroscience, 2013
The schizophrenia brain is differentiated from the normal brain by subtle changes, with significant overlap in measures between normal and disease states. For the past 25 years, schizophrenia has increasingly been considered a neurodevelopmental disorder.
Vibeke Sorensen Catts   +39 more
doaj   +1 more source

Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial

open access: yesBMC Psychiatry, 2021
Background Cannabis use is an important risk factor for development of psychosis and further transition to schizophrenia. The prevalence of patients with psychosis and comorbid cannabis use (dual diagnosis) is rising with no approved specialized ...
Jesper Østrup Rasmussen   +4 more
doaj   +1 more source

Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines

open access: yesJournal of Neuroinflammation, 2020
Background High inflammation status despite an absence of known infection characterizes a subpopulation of people with schizophrenia who suffer from more severe cognitive deficits, less cortical grey matter, and worse neuropathology. Transcripts encoding
Caitlin E. Murphy   +7 more
doaj   +1 more source

Abnormal Task Modulation of Oscillatory Neural Activity in Schizophrenia

open access: yesFrontiers in Psychology, 2013
Schizophrenia patients have deficits in cognitive function that are a core feature of the disorder. AX-CPT is commonly used to study cognition in schizophrenia, and patients have characteristic pattern of behavioral and ERP response.
Elisa C Dias   +6 more
doaj   +1 more source

Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia

open access: yesFrontiers in Immunology, 2020
Increased cytokine and inflammatory-related transcripts are found in the ventral midbrain, a dopamine neuron-rich region associated with schizophrenia symptoms.
Tertia D. Purves-Tyson   +12 more
doaj   +1 more source

Family-based association study of SELENBP1 in schizophrenia

open access: yes, 2009
The SELENBP1 gene previously was found to be up-regulated in microarray analysis of both peripheral blood cell and brain tissue samples from schizophrenia patients Quantitative PCR analysis subsequently corroborated the altered expression of SELENBP1 in ...
Kanazawa, Tetsufumi; Glatt, Stephen J.; Faraone, Stephen V.; Hwu, Hai-Gwo; Yoneda, Hiroshi; Tsuang, Ming T.   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy